Parasympatholytics: all 542 studies that test it
Page 6 of 6. Open to participants first (75), then studies with results posted, then the rest; newest registration first within each.
- Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant SpasticityCompletedNCT00358293Phase 1/2
- Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten Children?WithdrawnNCT00348166Phase 1
- An Effectiveness and Safety Study Comparing Oxybutynin Chloride Plus FLOMAX (Tamsulosin HCl) and Placebo Plus FLOMAX (Tamsulosin HCl) for the Treatment of Lower Urinary Tract Symptoms.CompletedNCT00338624Phase 3
- Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable Chronic Obstructive Pulmonary Disease (COPD)WithdrawnNCT00335621Phase 4
- Evaluation of Eperisone HCl in the Treatment of Acute Musculoskeletal Spasm Associated With Low Back Pain - A Double Blind, Randomised, Placebo Controlled Clinical TrialCompletedNCT00327730Phase 3
- "Death Rattle" - A Double Blind, Randomly Controlled, Crossover TrialTerminatedNCT00320892Not applicable
- A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPDCompletedNCT00308191Phase 3
- Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary IncontinenceCompletedNCT00304499Phase 3
- Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive BladderCompletedNCT00293839Phase 3
- Drotaverine in Dysmenorrhoea TreatmentTerminatedNCT00292747Phase 4
- A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00292448Phase 2
- Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI)CompletedNCT00287157Phase 1
- Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00281567Phase 3
- Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00279019Phase 1
- Spiriva® Assessment of FEV1 (SAFE)CompletedNCT00277264Phase 3
- Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different SeverityCompletedNCT00274573Phase 3
- A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.CompletedNCT00274560Phase 3
- Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00274547Phase 3
- A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.CompletedNCT00274534Phase 3
- Tiotropium (Spiriva) Rehabilitation StudyCompletedNCT00274521Phase 3
- Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD PatientsCompletedNCT00274508Phase 3
- SPIRIVA in Ususal CareCompletedNCT00274079Phase 4
- Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of SpirivaCompletedNCT00274066Phase 3
- Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPDCompletedNCT00274053Phase 3
- Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPDCompletedNCT00274040Phase 3
- Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)CompletedNCT00274027Phase 3
- Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory DisordersCompletedNCT00274014Phase 3
- Analysis of Atropine and Propranolol Induced ChangesCompletedNCT00251602Phase 1
- Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00239499Phase 4
- Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPDCompletedNCT00239460Phase 3
- Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPDCompletedNCT00239447Phase 3
- Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).CompletedNCT00239408Phase 4
- Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD PatientsCompletedNCT00157235Phase 3
- A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00144326Phase 3
- 12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)CompletedNCT00144196Phase 4
- High Dose Trial in COPDCompletedNCT00128440Phase 2
- An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years OldCompletedNCT00094692Phase 3
- Trial Comparing Daily Atropine Versus Weekend AtropineCompletedNCT00094614Phase 4
- Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.CompletedNCT00047580Phase 3
- Amblyopia (Lazy Eye) Treatment StudyCompletedNCT00001864Phase 3
- Evaluation of Benztropine for Cocaine Craving - 2CompletedNCT00000333Phase 2
- Occlusion Versus Pharmacologic Therapy for Moderate AmblyopiaCompletedNCT00000170Phase 3